CervoMed (CRVO) Common Equity (2022 - 2025)
Historic Common Equity for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to $26.0 million.
- CervoMed's Common Equity fell 4300.42% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year decrease of 4300.42%. This contributed to the annual value of $39.2 million for FY2024, which is 43142.92% up from last year.
- CervoMed's Common Equity amounted to $26.0 million in Q3 2025, which was down 4300.42% from $33.4 million recorded in Q2 2025.
- CervoMed's 5-year Common Equity high stood at $50.0 million for Q2 2024, and its period low was -$35.1 million during Q2 2023.
- For the 4-year period, CervoMed's Common Equity averaged around $15.4 million, with its median value being $26.0 million (2025).
- In the last 5 years, CervoMed's Common Equity crashed by 23165.62% in 2023 and then surged by 54902.61% in 2025.
- Quarter analysis of 4 years shows CervoMed's Common Equity stood at -$33.3 million in 2022, then soared by 122.16% to $7.4 million in 2023, then surged by 431.43% to $39.2 million in 2024, then plummeted by 33.65% to $26.0 million in 2025.
- Its Common Equity stands at $26.0 million for Q3 2025, versus $33.4 million for Q2 2025 and $34.6 million for Q1 2025.